Literature DB >> 16361053

Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population.

Constance E Ruhl1, James E Everhart.   

Abstract

BACKGROUND & AIMS: Both alcohol and obesity are associated with hepatic steatosis. However, little is known about whether the toxicity of alcohol to the liver is influenced by adiposity. We examined the relationship of alcohol drinking and binge drinking with abnormal serum aminotransferase activity in normal weight, overweight, and obese persons in a national, population-based study.
METHODS: Data were analyzed from 13,580 adult participants in the third US National Health and Nutrition Examination Survey, 1988-1994, after excluding participants with hepatitis B or C or iron overload. Abnormal aminotransferase levels were defined by using sex-specific cutoffs for ALT and AST. Analyses were adjusted for other liver injury risk factors.
RESULTS: The prevalence of abnormal aminotransferase activity was elevated with consumption of >2 drinks per day or with overweight and obesity. In multivariate analysis, there was no association of alcohol intake with a higher prevalence of elevated aminotransferase levels among normal weight persons. In contrast, among overweight persons, consumption of >2 drinks per day increased the risk of elevated aminotransferase levels, and among the obese, > or = 1 drink per day was associated with a higher risk. Results were similar with elevated ALT alone as the outcome. With elevated AST alone as the outcome, intake of >2 drinks per day increased the risk, even among normal weight persons. Binge drinking was associated with aminotransferase elevation among obese consumers of 1-2 drinks per day.
CONCLUSIONS: In this large, national, population-based study, overweight and obesity increased the risk of alcohol-related abnormal aminotransferase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361053     DOI: 10.1016/s1542-3565(05)00743-3

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  75 in total

1.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

2.  Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.

Authors:  Ghulam Ilyas; Francesca Cingolani; Enpeng Zhao; Kathryn Tanaka; Mark J Czaja
Journal:  Alcohol Clin Exp Res       Date:  2019-04-29       Impact factor: 3.455

Review 3.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

4.  What advice should be given to patients with NAFLD about the consumption of alcohol?

Authors:  Margaret S Sozio; Naga Chalasani; Suthat Liangpunsakul
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-18

5.  Liver fibrosis scores predict liver disease mortality in the United States population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2017-05-16       Impact factor: 17.425

6.  Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.

Authors:  Huafeng Shen; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2016-08       Impact factor: 3.062

7.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

8.  Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Authors:  Adeyinka C Adejumo; George Cholankeril; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; Waldo C Concepcion; Donghee Kim; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2019-08-01       Impact factor: 3.199

Review 9.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

Review 10.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.